Barrett's oesophagus patients attending hospital: Baseline clinical, patient history and quality of life data from BOSS and AspECT
From 2005 to 2011 two large UK studies recruited 6,327 evaluable patients with Barrett’s Oesophagus attending hospital clinics. Baseline clinical, patient history and quality of life data was collected prior to randomisation and this rich dataset is the basis for this abstract.
Principais autores: | Love, S, Reilly, G, Roberts, C, Wise, A, Moayyedi, P, Foy, C, Stokes, C, De Caestecker, J, Attwood, S, Watson, R, Ang, Y, Bhandari, P, Old, O, Hapeshi, J, Penman, I, Rodgers, C, Edwards, C, Monk, D, Ragunath, K, Morris, D, Johnston, D, Barr, H, Jankowski, J |
---|---|
Formato: | Conference item |
Publicado em: |
Elsevier
2016
|
Registros relacionados
-
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
por: Jankowski, J, et al.
Publicado em: (2018) -
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
por: Jankowski, J, et al.
Publicado em: (2018) -
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.
por: Fitzgerald, R, et al.
Publicado em: (2014) -
The changing world of clinical trials 2003-2017: A view from the AspECT trial
por: Reilly, G, et al.
Publicado em: (2017) -
Barrett's oesophagus and adenocarcinoma
por: Lao-Sirieix Pierre, et al.
Publicado em: (2004-05-01)